Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Cytosorbents Corp
CTSO
$56.7M
| $583K | ﹤0.01% |
73,100
-22,900
| -24% | -$183K |
|
2752
Smith Micro Software
SMSI
$15.1M
| $582K | ﹤0.01% |
+13,425
| New | +$582K |
|
|
ORC
2753
Orchid Island Capital
ORC
$1.05B
| $581K | ﹤0.01% |
22,279
-238,200
| -91% | -$6.21M |
|
2754
Beyond Air
XAIR
$15.5M
| $581K | ﹤0.01% |
+5,515
| New | +$581K |
|
|
TCS
2755
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $580K | ﹤0.01% |
4,053
+833
| +26% | +$119K |
|
2756
Vista Gold
VGZ
$255M
| $579K | ﹤0.01% |
536,200
+58,600
| +12% | +$63.3K |
|
|
OYST
2757
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $577K | ﹤0.01% |
30,639
-14,861
| -33% | -$280K |
|
|
OPOF
2758
DELISTED
Old Point Financial
OPOF
| $575K | ﹤0.01% |
30,335
+500
| +2% | +$9.48K |
|
2759
Goosehead Insurance
GSHD
$2.04B
| $574K | ﹤0.01% |
4,600
-6,200
| -57% | -$774K |
|
|
TRQ
2760
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $573K | ﹤0.01% |
+46,200
| New | +$573K |
|
2761
Vericel Corp
VCEL
$1.51B
| $571K | ﹤0.01% |
+18,492
| New | +$571K |
|
|
STAB
2762
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $571K | ﹤0.01% |
165,651
-41,100
| -20% | -$142K |
|
2763
BrightView Holdings
BV
$1.27B
| $570K | ﹤0.01% |
37,700
-10,200
| -21% | -$154K |
|
2764
Vanguard Information Technology ETF
VGT
$104B
| $566K | ﹤0.01% |
1,600
+100
| +7% | +$35.4K |
|
|
TECX
2765
Tectonic Therapeutic, Inc. Common Stock
TECX
$300M
| $566K | ﹤0.01% |
3,383
+2,108
| +165% | +$353K |
|
2766
Cellectar Biosciences
CLRB
$16.2M
| $563K | ﹤0.01% |
903
-568
| -39% | -$354K |
|
2767
Solid Biosciences
SLDB
$421M
| $563K | ﹤0.01% |
4,950
-1,560
| -24% | -$177K |
|
2768
Live Ventures
LIVE
$57.9M
| $561K | ﹤0.01% |
45,199
+10,398
| +30% | +$129K |
|
2769
Tecnoglass
TGLS
$3.27B
| $561K | ﹤0.01% |
+81,200
| New | +$561K |
|
2770
Travel + Leisure Co
TNL
$3.97B
| $561K | ﹤0.01% |
+12,507
| New | +$561K |
|
2771
GrafTech
EAF
$278M
| $560K | ﹤0.01% |
+5,250
| New | +$560K |
|
2772
Luxfer Holdings
LXFR
$375M
| $560K | ﹤0.01% |
34,100
-23,900
| -41% | -$392K |
|
|
DXYN
2773
DELISTED
Dixie Group Inc
DXYN
| $559K | ﹤0.01% |
219,300
+188,000
| +601% | +$479K |
|
|
HBMD
2774
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $557K | ﹤0.01% |
47,200
+4,280
| +10% | +$50.5K |
|
|
AVEO
2775
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $557K | ﹤0.01% |
+96,500
| New | +$557K |
|